Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Progyny Inc (NASDAQ: PGNY) closed at $21.81 down -1.22% from its previous closing price of $22.08. In other words, the price has decreased by -$1.22 from its previous closing price. On the day, 1.08 million shares were traded. PGNY stock price reached its highest trading level at $22.28 during the session, while it also had its lowest trading level at $21.71.
Ratios:
For a deeper understanding of Progyny Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.20 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.76. For the most recent quarter (mrq), Quick Ratio is recorded 2.80 and its Current Ratio is at 2.80. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On November 13, 2024, Truist Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $26 to $19.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 26 ’24 when Schlanger David J bought 150,000 shares for $14.68 per share. The transaction valued at 2,202,330 led to the insider holds 228,269 shares of the business.
Anevski Peter bought 209,500 shares of PGNY for $3,034,084 on Dec 23 ’24. The CHIEF EXECUTIVE OFFICER now owns 441,463 shares after completing the transaction at $14.48 per share. On Dec 09 ’24, another insider, SEIDENBERG BETH C, who serves as the Director of the company, bought 39,680 shares for $15.82 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGNY now has a Market Capitalization of 1868427776 and an Enterprise Value of 1654181760. As of this moment, Progyny’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.59, and their Forward P/E ratio for the next fiscal year is 26.41. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.49. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.60 while its Price-to-Book (P/B) ratio in mrq is 4.41. Its current Enterprise Value per Revenue stands at 1.417 whereas that against EBITDA is 23.42.
Stock Price History:
The Beta on a monthly basis for PGNY is 1.36, which has changed by -0.33404583 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, PGNY has reached a high of $34.40, while it has fallen to a 52-week low of $13.39. The 50-Day Moving Average of the stock is -0.97%, while the 200-Day Moving Average is calculated to be 6.50%.
Shares Statistics:
For the past three months, PGNY has traded an average of 1.79M shares per day and 1442630 over the past ten days. A total of 85.31M shares are outstanding, with a floating share count of 71.60M. Insiders hold about 16.43% of the company’s shares, while institutions hold 89.71% stake in the company. Shares short for PGNY as of 1743379200 were 6447898 with a Short Ratio of 3.59, compared to 1740700800 on 11371537. Therefore, it implies a Short% of Shares Outstanding of 6447898 and a Short% of Float of 9.56.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
